Drugs / BBM-A101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07198555 | Oct 2025 → Dec 2027 expected | osteoarthritis, knee | Belief BioMed (Beijing) Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BBM-A101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07198555 ↗ |
| Modality | Gene therapy (AAV / viral vector) | “AAVbased gene therapy” NCT07198555 ↗ |
| Route | Other | “Single-dose intra-articular （IA）injection （2ml）(phase Ia)” NCT07198555 ↗ |